-
psnet.ahrq.gov/node/49718/psn-pdf
January 01, 2015 - Oral potassium repletion is considered first-line therapy; intravenous repletion should be saved for … Hyperkalemia in hospitalized patients: causes,
adequacy of treatment, and results of an attempt to improve … physician compliance with published therapy
guidelines. … Therapeutic approach to hypokalemia. Nephron. 2002;92(suppl 1):28-32. [go to
PubMed]
10. … potassium concentration
Preparation of potassium salts
Potassium chloride: most effective and first line treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/d4i_combo_psi12-dvt-bestpractices.pdf
May 20, 2016 - Systems of Care
Introduction: Essential First Steps
• Engage key stakeholders, including pharmacy and therapeutics … Risk factors include:4,6,7
Active cancer or cancer treatment
Age over 60 years
Critical care … possible and take measures to reduce the amount of
time the patient is immobile because of the effects of treatment … o Review for appropriateness of therapy. … Venous thromboembolism diagnosis and treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - Although we are clear throughout that these
are unique diseases with unique treatments, a title
change … Supplemental treatment may include physical
therapy, occupational therapy, and treatment-
related surgery … Supplemental treatment may
include physical therapy, occupational therapy, and
treatment-related surgery … Adjunct treatments. It describes splenectomy as an option for
supportive care. … We
did not investigate any combination therapies for LSDs.
-
hcup-us.ahrq.gov/reports/statbriefs/sb171-Operating-Room-Procedure-Trends.jsp
March 01, 2014 - All-listed procedures include all procedures performed during the hospital stay, whether for definitive treatment … were defined using procedure classes, which categorize each ICD-9-CM procedure code as either major therapeutic … , major diagnostic, minor therapeutic, or minor diagnostic. 9
Table 2 lists the specific CCS procedure … However, if a patient received long-term care, rehabilitation, or treatment for psychiatric or chemical … âotherâ; procedures that are nonspecific and could be performed for a variety of reasons (e.g., treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
January 01, 2016 - Background
The administration of iodinated contrast
media is an essential component of many
diagnostic and therapeutic … object is to help
consumers, health care providers, and
others in making informed choices
among treatment … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … Secondary
outcomes were also considered, such as need for renal
replacement therapy (including dialysis … contrast media generally provided little
detail about clinical indications for the diagnostic or
therapeutic
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026322-dorsch-final-report-2021.pdf
January 01, 2021 - fibrillation (AF) is the most common cardiac arrhythmia in the US and oral
anticoagulation (OAC) is a therapeutic … Anticoagulation is a therapeutic option in AF given the inherent risk of
stroke, but guidelines are … This leads to inflation of a score without informing the relative benefit or risk of the
therapy. … patients from anticoagulation therapy … Providers are less likely to
recommend anticoagulation therapy in the elderly, despite evidence that
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-disseminating-findings_0.pdf
October 01, 2018 - instance, the selected report did not consider the balance of benefits and
harms for a particular therapy … risk for contrast media within and between
osmolality classes in patients receiving diagnostic or therapeutic … between IOCM and LOCM for secondary outcomes, such as cardiac
events, need for renal replacement therapy … classes, affect the
risk of contrast-induced nephropathy (CIN) in patients receiving diagnostic or therapeutic … contrast-induced nephropathy (CIN)
• Secondary outcomes: patient characteristics (renal replacement therapy
-
psnet.ahrq.gov/perspective/count-and-be-counted-preparing-future-pharmacists-promote-culture-safety
April 01, 2006 - Typically, pharmacists spend little or no time assessing the patient for therapeutic or adverse drug … care (eg, immunizations), and partner with physicians and nurses to use evidence-based, cost-effective treatments … We have taught our students well to solve therapeutic problems through the use of case studies and advanced … With medication management therapy, we're starting to see for the first time pharmacists being able to … be reimbursed for talking to a patient, educating them, and monitoring their therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - have been
studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement
Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic
use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug
therapy’/exp OR ‘therapeutic
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZcLsqV-5K7hyfot-qHQp9
November 01, 2004 - Although these cancers
recur frequently after treatment, they rarely invade
muscle and rarely cause clinically … The
effectiveness of treatment for those with high-grade
bladder cancer is uncertain.10 The variability … We then combined
bladder neoplasms with therapeutics/treatment (1,984
citations) and combined those results … Does treatment of early-stage
bladder cancer reduce morbidity and
mortality from this disease?
-
hcup-us.ahrq.gov/reports/statbriefs/sb256-Opioids-Endocarditis-Inpatient-Stays-2016.pdf
January 01, 2016 - Updated July 19, 2019. my.clevelandclinic.org/health/treatments/17125-infective-
endocarditis-surgery … /health/treatments/17125-infective-endocarditis-surgery
3
Findings
Trends in inpatient stays … use
E935.1 Methadone causing adverse effects in therapeutic use
E935.2 Other opiates and related narcotics … causing adverse effects in therapeutic use
E940.1 Adverse effects of opiate antagonists
ICD-10-CM … However, if a patient received long-term care, rehabilitation,
or treatment for a psychiatric or chemical
-
psnet.ahrq.gov/node/49521/psn-pdf
September 12, 2006 - She responded well to medical
therapy, and surgical valve repair was scheduled. … she noticed that the patient was receiving penicillamine (a non-antibiotic
medication used in the treatment … The survey included a series of test orders with problems such as therapeutic duplication,
drug-drug … selection likely would have prevented the error in this case, because penicillamine is used for
the treatment
-
psnet.ahrq.gov/web-mm/troubling-amine
September 01, 2003 - She responded well to medical therapy, and surgical valve repair was scheduled. … , she noticed that the patient was receiving penicillamine (a non-antibiotic medication used in the treatment … The survey included a series of test orders with problems such as therapeutic duplication, drug-drug … selection likely would have prevented the error in this case, because penicillamine is used for the treatment
-
psnet.ahrq.gov/web-mm/citrate-mix
February 01, 2010 - and chronic renal failure was transferred from a skilled nursing facility (SNF) to the hospital for treatment … This error led to increased patient monitoring and drug treatment to normalize the serum potassium and … The formulary review process of the Pharmacy and Therapeutics Committee can be a forum to discuss limiting … The hospital's Pharmacy and Therapeutics Committee can develop prescribing guidelines for using these … citrate agents that inform staff of their differences and suggest therapeutic alternatives.
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-4
January 01, 2023 - , David
Project Name
Health Information Technology Center for Education and Research on Therapeutics
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/human-factors-considerations-for-contraindication-alerts
January 01, 2023 - , David
Project Name
Health Information Technology Center for Education and Research on Therapeutics
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/initiative
January 01, 2023 - , David
Project Name
Health Information Technology Center for Education and Research on Therapeutics
-
psnet.ahrq.gov/node/33921/psn-pdf
October 10, 2018 - connection to existing
hospital infrastructure designed with overlapping goals (e.g., Pharmacy and Therapeutics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
January 01, 2010 - If patients are choosing between two treatments, CE research does not study treatment 1 versus placebo … but rather compares treatment 1 versus treatment 2. … Anderson Cancer Center and Baylor College of Medicine
Therapies for heart and blood vessel disorders … use and resistance — University of Pennsylvania School of Medicine
Therapeutic medical devices — Weill … New Jersey
Therapies for older adults and the effects of aging — University of Iowa
Pediatric therapeutics
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction.ppt
January 01, 2010 - If patients are choosing between two treatments, CE research does not study treatment 1 versus placebo … but rather compares treatment 1 versus treatment 2. … Anderson Cancer Center and Baylor College of Medicine
Therapies for heart and blood vessel disorders … use and resistance — University of Pennsylvania School of Medicine
Therapeutic medical devices — Weill … New Jersey
Therapies for older adults and the effects of aging — University of Iowa
Pediatric therapeutics